ArticleOncoimmunology2023
FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer.
Lu Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncoimmunology2023
Lu Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.